Dr. Fernando E. Kafie, MD

Dr. Kafie practices at Azura Surgery Center Plantation in Plantation, Florida.

Dr. Kafie's NPI, 1790760478, was assigned on December 14, 2005. Dr. Kafie graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Kafie holds Florida license ME81407.

Dr. Kafie's primary practice is Azura Surgery Center Plantation, at 6766 W Sunrise Blvd, Ste 100, Plantation, FL 33313. The practice phone is (954) 583-8472.

Dr. Kafie's primary practice is Azura Surgery Center Plantation in Plantation, Florida. The medical group on file is Azura Vascular Care Plantation. Dmand AI also links Dr. Kafie to 5 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kafie practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Kafie's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Kafie is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Kafie's licenses on file in 2 states: Florida and California.

Dmand AI lists amputation, aortic atherosclerois, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and lymphedema among the conditions Dr. Kafie treats.

CMS data shows 2,645 Medicare services from Dr. Kafie across 38 procedure codes in 2024, for 855 Medicare patients. Medicare paid $515,159 for them.

CMS counts 855 Medicare patients who saw Dr. Kafie in 2024. The largest group is 75 to 84, with 362 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kafie's median patient age at 68, with 40% women.

In 2024, Dr. Kafie wrote 612 Medicare Part D claims for 277 patients. 70% of them were for generic drugs. CMS names the drug for 551 of them, across 6 drugs with 11 or more claims each, at $178,361 in total drug cost. In 2023, CMS named 918 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kafie for performance year 2024, reported as part of a group. Dr. Kafie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Kafie in 2001. The most frequent topics are Rabbits, Disease Models, Animal and Pneumonectomy. Dr. Kafie has published most often in J Invest Surg. Dr. Kafie's most frequent co-authors are Matthew Brenner, MD, Adrian W. Gelb, MD and Arthur Franklin Gelb, MD.

Dmand AI links Dr. Kafie to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Arteriovenous Fistula, Vascular Fistula and Peripheral Arterial Disease.

CMS Open Payments shows 557 general payments to Dr. Kafie from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Medtronic, Inc. paid the most, $4,416.

Dmand AI lists 2 awards for Dr. Kafie, most recently CMS Stage 1 2012 in 2011.

Dr. Kafie graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Kafie is a member of ACS and SVS.

Dr. Kafie is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.